COLL vs MCD
Collegium Pharmaceutical Inc (COLL) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the COLL and MCD stock pages for the full models.
Not investment advice.